Page last updated: 2024-08-21

lactulose and naltrexone

lactulose has been researched along with naltrexone in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Foss, JF; Karrison, T; Moss, J; O'Connor, M; Osinski, J; Roizen, MF; Yuan, CS	1
Candy, B; Drake, R; Goodman, ML; Jones, L; Tookman, A	1
Candy, B; Jones, L; Larkin, PJ; Stone, P; Tookman, A; Vickerstaff, V	1

Reviews

3 review(s) available for lactulose and naltrexone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Laxatives or methylnaltrexone for the management of constipation in palliative care patients. The Cochrane database of systematic reviews, 2011, Jan-19, Issue:1 Topics: Analgesics, Opioid; Anthraquinones; Cathartics; Constipation; Humans; Lactulose; Magnesium Hydroxide; Naltrexone; Palliative Care; Paraffin; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Senna Extract	2011
Laxatives for the management of constipation in people receiving palliative care. The Cochrane database of systematic reviews, 2015, May-13, Issue:5 Topics: Analgesics, Opioid; Anthraquinones; Cathartics; Constipation; Humans; Lactulose; Magnesium Hydroxide; Naltrexone; Palliative Care; Paraffin; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Senna Extract	2015

Trials

1 trial(s) available for lactulose and naltrexone

Article	Year
Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time. Clinical pharmacology and therapeutics, 2000, Volume: 67, Issue:4 Topics: Administration, Oral; Adult; Breath Tests; Double-Blind Method; Female; Gastrointestinal Agents; Gastrointestinal Transit; Humans; Lactulose; Male; Morphine; Naltrexone; Narcotic Antagonists; Pilot Projects; Quaternary Ammonium Compounds; Tablets, Enteric-Coated; Time Factors	2000

Article

Year

Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.

Clinical pharmacology and therapeutics, 2000, Volume: 67, Issue:4

Topics: Administration, Oral; Adult; Breath Tests; Double-Blind Method; Female; Gastrointestinal Agents; Gastrointestinal Transit; Humans; Lactulose; Male; Morphine; Naltrexone; Narcotic Antagonists; Pilot Projects; Quaternary Ammonium Compounds; Tablets, Enteric-Coated; Time Factors

2000

Other Studies

2 other study(ies) available for lactulose and naltrexone

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011